Opinion|Videos|August 19, 2024
Key Takeaways on Enhancing Outcomes for mNSCLC Without Targetable Driver Mutations
The panel provides insights on enhancing outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Looking ahead, what is the most critical priority to meaningfully enhance outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?
2
What Comes After Anti-VEGF in Wet AMD: Arshad Khanani, MD
3
FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication
4
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
5